CN115125290A - Amplification method of multiple single strands and application thereof - Google Patents

Amplification method of multiple single strands and application thereof Download PDF

Info

Publication number
CN115125290A
CN115125290A CN202210930956.6A CN202210930956A CN115125290A CN 115125290 A CN115125290 A CN 115125290A CN 202210930956 A CN202210930956 A CN 202210930956A CN 115125290 A CN115125290 A CN 115125290A
Authority
CN
China
Prior art keywords
amplification
primer
target
linear
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210930956.6A
Other languages
Chinese (zh)
Other versions
CN115125290B (en
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Lukang Haoliyou Biotechnology Development Co ltd
Original Assignee
Shandong Lukang Haoliyou Biotechnology Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Lukang Haoliyou Biotechnology Development Co ltd filed Critical Shandong Lukang Haoliyou Biotechnology Development Co ltd
Priority to CN202210930956.6A priority Critical patent/CN115125290B/en
Publication of CN115125290A publication Critical patent/CN115125290A/en
Application granted granted Critical
Publication of CN115125290B publication Critical patent/CN115125290B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a multiplex single-chain amplification method and application thereof.A linear primer, an upstream target primer and a downstream target primer are placed in an amplification reaction system for amplification reaction, and the amplification reaction comprises exponential amplification and linear amplification; the upstream target primer and the downstream target primer are respectively a mixture of multiple target primers; the linear primer is a non-target related sequence and is in a half-half complementary hairpin structure form; the upstream target primer is formed by connecting a target specificity sequence and a linear primer sequence in series, wherein the target specificity sequence is at the 3 'end, and the linear primer sequence is at the 5' end. The multiple single-strand amplification method has the advantages of high sensitivity, good specificity, good universality, high multiple single-strand yield, high single-strand yield and good uniformity of yield of each target single strand, and can be applied to nucleic acid hybridization amplification.

Description

Amplification method of multiple single strands and application thereof
Technical Field
The invention belongs to the technical field of biological detection, and particularly relates to a multiplex single-chain amplification method and application thereof.
Background
With the popularization and application of gene detection in modern clinical medical diagnosis, nucleic acid hybridization is increasingly widely applied in various diagnostic detection methodologies, such as gene chip, reverse dot hybridization, second generation sequencing, nucleic acid capture, nucleic acid aptamer screening, Southern hybridization, Northern hybridization and the like.
In nucleic acid hybridization applications, preparation of single-stranded nucleic acids is involved, and is mainly achieved by methods such as chain polymerase amplification (PCR), double-stranded nucleic acid thermal denaturation treatment, double-stranded nucleic acid alkali denaturation treatment, chemical synthesis and the like.
The chain polymerase amplification (PCR) method, one by linear amplification, is limited by the number of templates and generally yields very low. One is amplification by asymmetric PCR, but when a plurality of target primers are simultaneously amplified, the mutual interference is serious, and single-stranded products of each target cannot be covered. The thermal denaturation treatment of double-stranded nucleic acid is complicated in operation and has high requirements for temperature and time control, and denatured single-stranded nucleic acid is easily denatured into double-stranded nucleic acid and has poor stability. The alkali denaturation treatment of the double-stranded nucleic acid has certain destructiveness to the nucleic acid, needs strict pH value control and subsequent pH value neutralization reaction, and is complex to operate. The chemical synthesis of single-stranded nucleic acid is costly, and especially the synthesis of long-fragment single-stranded nucleic acid is difficult.
Therefore, the development of a multiplex single-stranded amplification method which is simple in operation, high in single-stranded yield, free of interference and low in cost is of great significance.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a multiplex single-chain amplification method and application thereof.
The invention is realized by the following technical scheme:
a multiple single-chain amplification method is characterized in that a linear primer, an upstream target primer and a downstream target primer are placed in an amplification reaction system for amplification reaction, and the amplification reaction comprises exponential amplification and linear amplification;
the upstream target primer and the downstream target primer are respectively a mixture of multiple target primers;
the linear primer is a non-target related sequence and is in a half-half complementary hairpin structure form;
the upstream target primer is formed by connecting a target specificity sequence and a linear primer sequence in series, wherein the target specificity sequence is at the 3 'end, and the linear primer sequence is at the 5' end.
Further, the amplification reaction also comprises denaturation treatment.
Further, the sequence length of the linear primer is 30 bp-60 bp, and T is m The value is 56-80 ℃; the upstream target primer has long target specific sequenceThe degree is 14 bp to 22 bp, T m The value is 42-55 ℃; the downstream target primer sequence length is 14 bp-22 bp, T m The value is 42 ℃ to 55 ℃.
Furthermore, the concentration of the linear primer in the amplification reaction system is 0.3-2 mu M, the concentration of the upstream target primer is 0.02-0.6 mu M, and the concentration of the downstream target primer is 0.1-1.2 mu M.
Further, the amplification reaction system meets the condition that the concentration of the linear primer is more than that of the downstream target primer is more than that of the upstream target primer.
Further, the exponential amplification is the first round of amplification, the annealing temperature is 42-55 ℃, and the amplification cycle number is 15-45 cycles; the linear amplification is the second round of amplification, the annealing temperature is 56-72 ℃, and the amplification cycle number is 1-25 cycles.
Further, the denaturation treatment is a third round of amplification, and the heat treatment is carried out at 98 ℃ for 0-15 min and at 4 ℃ for 0-15 min.
Furthermore, the linear primer is modified at the 5' end of the sequence, and the modifying group is one of biotin, digoxin, quantum dots, FAM, VIC, Cy5 and Cy 3.
In the invention, the amplification method of the multiple single strands is applied to nucleic acid hybridization amplification.
According to the invention, the first round of exponential amplification is carried out, and under the condition of low annealing temperature, a large amount of double-stranded primers are generated by target primer amplification; performing second round of linear amplification, wherein under the condition of high annealing temperature, the modified primers are amplified in a large quantity to generate a large quantity of modified single-stranded primers; the third round of denaturation treatment can increase the quantity of single-chain products, and selection can be made according to the actual detection sensitivity requirement.
Advantageous effects
According to the invention, the linear primer, the upstream target primer and the downstream target primer are placed in an amplification reaction system for amplification reaction, and the multiple single-stranded amplification method has the advantages of high sensitivity, good specificity, good universality, high multiple single-stranded yield, high single-stranded yield and high uniformity of the yield of each target single strand.
Drawings
FIG. 1 is a diagram of a probe immobilization array for each HPV type;
FIG. 2 shows HPV16 of human papillomavirus at a concentration of 10 6 、10 2 IU/mL time detection result chart;
FIG. 3 shows HPV18 of human papillomavirus at a concentration of 10 6 、10 2 IU/mL time detection result chart;
FIG. 4 shows HPV31 of human papillomavirus at a concentration of 10 6 、10 2 IU/mL time detection result chart;
FIG. 5 shows HPV33 of human papillomavirus at a concentration of 10 6 、10 2 IU/mL time detection result chart;
FIG. 6 shows HPV35 of human papillomavirus at a concentration of 10 6 、10 2 IU/mL detection result graph;
FIG. 7 shows HPV39 of human papillomavirus at a concentration of 10 6 、10 2 IU/mL time detection result chart;
FIG. 8 shows HPV45 from human papillomavirus at a concentration of 10 6 、10 2 IU/mL time detection result chart;
FIG. 9 shows human papillomavirus HPV51 at a concentration of 10 6 、10 2 IU/mL detection result graph;
FIG. 10 shows HPV52 from human papillomavirus at a concentration of 10 6 、10 2 IU/mL time detection result chart;
FIG. 11 shows human papillomavirus HPV56 at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 12 shows human papillomavirus HPV58 at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 13 shows HPV59 from human papillomavirus at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 14 shows HPV66 from human papillomavirus at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 15 shows human papillomavirus HPV68 at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 16 shows HPV26 of human papillomavirus at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 17 shows HPV53 human papillomavirus at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 18 shows HPV73 human papillomavirus at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 19 shows HPV82 from human papillomavirus at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 20 shows HPV6 from human papillomavirus at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 21 human papillomavirus HPV11 at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 22 shows human papillomavirus HPV42 at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 23 shows human papillomavirus HPV43 at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 24 shows human papillomavirus HPV81 at a concentration of 10 6 、10 2 A detection result chart under IU/mL;
FIG. 25 is a diagram showing the results of detection of cross-interferents CMV, HSV-1, CT, GBS, UU and water.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and the described embodiments are only some embodiments, but not all embodiments, of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Amplification and detection of 23 human papilloma virus multiple single chains
(1) Primers for each HPV type were synthesized by Shanghai Biotechnology engineering, Inc. and the sequences are shown in Table 1 below:
TABLE 1 sequence Listing of Linear primers, upstream target primers and downstream target primers for each HPV type
Figure DEST_PATH_IMAGE002
Figure DEST_PATH_IMAGE004
Figure DEST_PATH_IMAGE006
Figure DEST_PATH_IMAGE008
(2) The linear primers (biotin modified at the 5' end of the sequence) were diluted to 10 μ M, each of the upstream and downstream target primers were diluted to 100 μ M, and then each of the upstream and downstream target primers were mixed together. HPV amplification template, human papillomavirus typing national reference from midhospital, diluting the national reference of each type to 10 according to the operation requirement 6 IU/mL、10 2 IU/mL, and simultaneously, respectively extracting nucleic acid by using virus bacteria CMV, HSV-1, CT, GBS and UU as cross-interference substances.
(3) Preparing a 23-fold single-strand amplification reaction system as shown in the following table 2:
TABLE 223 heavy HPV Single Strand amplification reaction System composition
Figure DEST_PATH_IMAGE009
(4) The amplification procedure of the 23-plex HPV single-strand amplification reaction system is shown in table 3 below:
TABLE 323 amplification procedure for heavy HPV Single Strand amplification reaction System
Figure DEST_PATH_IMAGE010
(5) Probe immobilization
Probes for each HPV type were synthesized by Shanghai Bioengineering, Inc. and the sequences are shown in Table 4 below:
TABLE 4 sequence Listing of probes for various HPV types
Figure DEST_PATH_IMAGE011
A probe immobilization kit originated from Shandong anti-Liriomo Biotechnology development Co., Ltd. (1) According to the requirements of the specification, diluting each probe to 50 μ M concentration, mixing and uniformly mixing with a nucleic acid fixing solution according to the volume ratio of 1:4, spotting on a nitrocellulose membrane by using a spotting instrument, baking for 10min at 50 ℃, immersing in a sealing solution, soaking for 10min at 50 ℃, and taking out the nitrocellulose membrane to obtain the nitrocellulose membrane fixed with each probe, wherein the probe fixing array is shown in figure 1:
(6) hybridization assay
The hybridization kit (biotin-streptavidin-alkaline phosphatase method) was from Shandong anti-Haolimo biotechnological development, Inc., and the detection steps are shown in Table 5 below:
TABLE 5 hybridization detection procedure
Figure DEST_PATH_IMAGE012
(7) The result of the detection is that,
various HPV types (HPV 16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, HPV66, HPV68, HPV26, HPV53, HPV73, HPV82, HPV6, HPV11, HPV42, HPV 43) at different concentrations (10 HPV16, HPV18, HPV 43) 6 IU/mL、10 2 IU/mL), and the detection results of the cross-interferents CMV, HSV-1, CT, GBS, UU and water are shown in FIGS. 2 to 25, and it can be seen that the concentration is 10 at a high concentration 6 Under the IU/mL template condition, all HPV types can be correctly detected, cross reaction does not exist among all HPV types, and cross reaction does not exist with CMV, HSV-1, CT, GBS and UU, so that the specificity is good. At a low concentration of 10 2 IU/mL of template conditions, eachThe HPV types can be obviously detected, and the sensitivity is high. In the invention, the 23-fold single-strand amplification can correctly amplify the single-strand products corresponding to the target, and the single-strand products are enough in quantity, high in sensitivity and good in specificity.

Claims (9)

1. A multiple single-chain amplification method is characterized in that a linear primer, an upstream target primer and a downstream target primer are placed in an amplification reaction system for amplification reaction, and the amplification reaction comprises exponential amplification and linear amplification;
the upstream target primer and the downstream target primer are respectively a mixture of multiple target primers;
the linear primer is a non-target related sequence and is in a half-half complementary hairpin structure form;
the upstream target primer is formed by connecting a target specificity sequence and a linear primer sequence in series, wherein the target specificity sequence is at the 3 'end, and the linear primer sequence is at the 5' end.
2. The method for amplifying multiple single strands according to claim 1, wherein the amplification reaction further comprises a denaturing treatment.
3. The method for amplifying multiple single strands according to claim 1, wherein the linear primer has a sequence length of 30bp to 60bp, T m The value is 56-80 ℃; the length of a target specific sequence in the upstream target primer is 14 bp-22 bp, and T m The value is 42-55 ℃; the downstream target primer sequence length is 14 bp-22 bp, T m The value is 42 ℃ to 55 ℃.
4. The method for amplifying a single stranded nucleic acid according to claim 1, wherein the concentration of the linear primer in the amplification reaction system is 0.3 to 2 μ M, the concentration of the upstream target primer is 0.02 to 0.6 μ M, and the concentration of the downstream target primer is 0.1 to 1.2 μ M.
5. The method for amplifying multiple single strands according to claim 4, wherein the amplification reaction system satisfies the conditions of linear primer concentration > downstream target primer concentration > upstream target primer concentration.
6. The method for amplifying a multiple single strand according to claim 1, wherein the exponential amplification is a first round of amplification, the annealing temperature is 42 to 55 ℃, and the number of amplification cycles is 15 to 45 cycles; the linear amplification is the second round of amplification, the annealing temperature is 56-72 ℃, and the amplification cycle number is 1-25 cycles.
7. The method for amplifying a single stranded nucleic acid according to claim 2, wherein the denaturation treatment is a third round of amplification, and the heat treatment is performed at 98 ℃ for 0 to 15 min and at 4 ℃ for 0 to 15 min.
8. The method for amplifying multiple single strands according to claim 1, wherein the linear primer is modified at the 5' end of the sequence, and the modifying group is one of biotin, digoxin, quantum dots, FAM, VIC, Cy5, and Cy 3.
9. Use of the method for amplifying multiple single strands according to any one of claims 1 to 8 in nucleic acid hybridization amplification.
CN202210930956.6A 2022-08-04 2022-08-04 Amplification method of multiple single strands and application thereof Active CN115125290B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210930956.6A CN115125290B (en) 2022-08-04 2022-08-04 Amplification method of multiple single strands and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210930956.6A CN115125290B (en) 2022-08-04 2022-08-04 Amplification method of multiple single strands and application thereof

Publications (2)

Publication Number Publication Date
CN115125290A true CN115125290A (en) 2022-09-30
CN115125290B CN115125290B (en) 2023-04-07

Family

ID=83385501

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210930956.6A Active CN115125290B (en) 2022-08-04 2022-08-04 Amplification method of multiple single strands and application thereof

Country Status (1)

Country Link
CN (1) CN115125290B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121364A1 (en) * 2000-02-07 2004-06-24 Mark Chee Multiplex nucleic acid reactions
US20090291475A1 (en) * 2008-04-23 2009-11-26 Kai Qin Lao Sequence amplification with linear primers
WO2010147848A2 (en) * 2009-06-15 2010-12-23 Rd Biosciences, Inc. Kits and methods for selective amplification and detection of nucleic acid targets
CN103614478A (en) * 2013-12-03 2014-03-05 浙江农林大学 Preparation method of single-strand long probe for multiple detection
CN110446787A (en) * 2017-03-24 2019-11-12 生物辐射实验室股份有限公司 General clamp primers
CN113755558A (en) * 2021-08-27 2021-12-07 万子健生物技术(上海)有限公司 Nucleic acid detection method based on liquid chip technology

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121364A1 (en) * 2000-02-07 2004-06-24 Mark Chee Multiplex nucleic acid reactions
US20090291475A1 (en) * 2008-04-23 2009-11-26 Kai Qin Lao Sequence amplification with linear primers
WO2010147848A2 (en) * 2009-06-15 2010-12-23 Rd Biosciences, Inc. Kits and methods for selective amplification and detection of nucleic acid targets
CN103614478A (en) * 2013-12-03 2014-03-05 浙江农林大学 Preparation method of single-strand long probe for multiple detection
CN110446787A (en) * 2017-03-24 2019-11-12 生物辐射实验室股份有限公司 General clamp primers
CN113755558A (en) * 2021-08-27 2021-12-07 万子健生物技术(上海)有限公司 Nucleic acid detection method based on liquid chip technology

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GUO-LEI WANG ET,AL.: "Sensitive detection of microRNAs with hairpin probe-based circular exponential amplification assay", 《ANAL CHEM.》 *

Also Published As

Publication number Publication date
CN115125290B (en) 2023-04-07

Similar Documents

Publication Publication Date Title
CN108192956B (en) Cas9 nuclease-based DNA detection and analysis method and application thereof
JP3659646B2 (en) Detection of human papillomavirus by nucleic acid amplification method using universal primers
CN101435002B (en) Method for detecting human papilloma virogene type
CN106834547B (en) Kit for human papilloma virus E6/E7 gene detection based on real-time isothermal amplification and application thereof
CN101818213B (en) Gene chip and kit for detecting human papillomavirus (HPV)
JP2009034081A (en) Primer set and probe for detecting human papilloma virus
CN102367490A (en) Method for detecting viruses
CN117625844A (en) Multiplex Q-PCR detection kit for HPV virus and preparation thereof
CN108546785B (en) Method for detecting DNA of pathogenic microorganisms in genital tract
CN107177684B (en) Constant temperature nucleic acid amplification reaction reagent
CN108179226B (en) Nucleic acid composition for detecting human papilloma virus, application thereof and kit
CN115125290B (en) Amplification method of multiple single strands and application thereof
CN108728578A (en) Detect the method and kit of a variety of high-risk human mammilla papillomavirus and its hypotype simultaneously in single tube reaction
CN110656203B (en) Human papilloma virus typing detection method, reagent and application
CN114164305A (en) Primer and typing probe combination for detecting human papilloma virus and application thereof
Jeney et al. Detection and typing of 46 genital human papillomaviruses by the L1F/L1R primer system based multiplex PCR and hybridization
Baines et al. Consensus-degenerate hybrid oligonucleotide primers (CODEHOP) for the detection of novel papillomaviruses and their application to esophageal and tonsillar carcinomas
Lee et al. High-resolution melting molecular signatures for rapid identification of human papillomavirus genotypes
CN111172328A (en) Complete set of primers, complete set of probes, kit and method for HPV nucleic acid typing detection
Erali et al. Human papillomavirus genotyping using an automated film-based chip array
CN112195277B (en) Primer probe set and kit for detecting human papilloma virus based on real-time fluorescent quantitative PCR
CN116555486B (en) Kit for detecting 14 high-risk human papilloma virus E6/E7 region mRNA
CN114045330B (en) Nucleic acid isothermal amplification method based on sliding replication
US20220340985A1 (en) Materials and methods for detecting human papilloma virus
CN118166163A (en) Multiple PCR detection kit for high-risk human papilloma virus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant